EWA
KYNB

Evolution Wealth Advisors’s Kyntra Bio KYNB Stock Holding History

Evolution Wealth Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10
Closed -$7K – 669
2021
Q2 		$7K Hold
10
– – ﹤0.01% 458
2021
Q1 		$9K Hold
10
– – ﹤0.01% 427
2020
Q4 		$9K Hold
10
– – ﹤0.01% 358
2020
Q3 		$10K Hold
10
– – ﹤0.01% 351
2020
Q2 		$10K Hold
10
– – ﹤0.01% 286
2020
Q1 		$9K Buy
10
+1
+11% +$994 ﹤0.01% 216
2019
Q4 		$10K Buy
9
+8
+800% +$8.17K ﹤0.01% 302
2019
Q3 		$1K Sell
1
-8
-89% -$8.79K ﹤0.01% 458
2019
Q2 		$10K Buy
+9
New +$9.85K ﹤0.01% 174

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Evolution Wealth Advisors's KYNB Position: Q3 2021 in Review

Evolution Wealth Advisors sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 10 shares — an estimated $7K sold.

Evolution Wealth Advisors first reported a position in KYNB in Q2 2019 and held it in 9 quarters. The position peaked at $10K in Q3 2020. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.

  • Evolution Wealth Advisors reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 10 Kyntra Bio shares in Q3 2021, an estimated $7K.
  • Evolution Wealth Advisors first reported a position in Kyntra Bio in Q2 2019 and held it in 9 quarters.
  • Evolution Wealth Advisors's Kyntra Bio position peaked at $10K in Q3 2020.
  • 164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.

Based on Evolution Wealth Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.